VitriVax announces Series A financing to further demonstrate feasibility of its thermostable, single-dose vaccine technology, aiming to make life-saving biologics widely accessible to underserved populations globally | Innovation & Entrepreneurship Initiative | University of Colorado Boulder Skip to main content
VitriVax announces Series A financing to further demonstrate feasibility of its thermostable, single-dose vaccine technology, aiming to make life-saving biologics widely accessible to underserved populations globally